Impakter
  • Environment
    • Biodiversity
    • Climate Change
    • Circular Economy
    • Energy
  • FINANCE
    • ESG News
    • Sustainable Finance
    • Business
  • TECH
    • Start-up
    • AI & Machine Learning
    • Green Tech
  • Industry News
    • Entertainment
    • Food and Agriculture
    • Health
    • Politics & Foreign Affairs
    • Philanthropy
    • Science
    • Sport
  • Editorial Series
    • SDGs Series
    • Shape Your Future
    • Sustainable Cities
      • Copenhagen
      • San Francisco
      • Seattle
      • Sydney
  • About us
    • Company
    • Team
    • Global Leaders
    • Partners
    • Write for Impakter
    • Contact Us
    • Privacy Policy
No Result
View All Result
Impakter logo
No Result
View All Result
Countering the Counterfeits: An Interview with Dr. Ashifi Gogo

Countering the Counterfeits: An Interview with Dr. Ashifi Gogo

Mr. Mohamad Akef - ColuminstbyMr. Mohamad Akef - Columinst
January 25, 2018
in Health, Science, Society, Tech
0

Modern medicine has helped make many diseases and scourges of the past far less threatening than ever before, enabling human health and standards of living to rise across the board. Traditional viruses and diseases like smallpox and polio have been either eradicated or significantly tamed, and many other afflictions that once spelled disaster are under attack as well.

Unfortunately for many across the world, the rise of modern medicine has led to the rise of modern counterfeits, made to take advantage of people’s fear and desperation. While figures are hard to come by, the CDCs estimate that between 10-30% of all medications sold in emerging market countries are fakes. Industrialized countries haven’t been completely spared from this trend either, as the increase in global connectivity has allowed more counterfeiters to hawk their fake wares worldwide. But while many people have known about the existence of counterfeits for decades, sifting through which medicines are good and fake has been far more challenging throughout that time. At least, that was the case until Sproxil showed up.

AshifiGogo_-_CopyBorn out of a desire to protect consumers and make them more informed about their purchases, Sproxil helps better connect companies with their customers through the use of a scratchable label system. Manufacturers apply labels with unique identifiers on their products, which can then be texted by buyers at the point of sale to verify if they are genuine or counterfeit. Sproxil has also used the label system to develop customer loyalty programs and supply chain analytics systems as the company has grown, underscoring its versatility. I reached out to Dr. Ashifi Gogo, founder and CEO of Sproxil, to learn more about the label system, Sproxil’s suite of products, and its impact on society.

What was the original inspiration behind Sproxil?

Ashifi Gogo: Sproxil stemmed from efforts to put unique codes on products in the organic produce industry. After discovering that consumers generally trusted organic produce retailers, a decision was taken to pursue products in situations where there was less trust between seller and buyer: pharmaceuticals in emerging markets. We subsequently launched in Nigeria in 2010, and have been growing ever since.

The initial idea was to use unique identifiers to help consumers know the origin of the organic produce they are buying. At the time there was produce at grocery stores that was being marketed as organic but wasn’t truly organic. However, we were finding it difficult to get consumers to take action to authenticate at the point of purchase. What we learned from that was that the products needed to have more urgent uses and greater consequences if found to be counterfeit, to get people to buy in.

Sproxil relies on a system of unique label codes placed by the manufacturer. What is the typical process like for convincing a manufacturer to start using your labels?

AG: Counterfeiting is a billion dollar industry that has infiltrated nearly every sector. Many of our clients understand the risks associated with counterfeiting and want to protect their consumers and their brand. We typically seek similar alignment with prospective clients through our industry events, and have subsequent in-depth conversations with brand owners where we can showcase the detailed insights they can access on our platform. Typically, once prospective clients understand the power of having real-time data on the product’s performance from its verifications volume, and the impact that has on their overall marketing strategy, the decision to sign up is straightforward.

Original GlucophageIn the Photo: Medicine being verified using a Sproxil label. Photo Credit: Sproxil.

While Sproxil was originally used to combat counterfeit medications, it’s now been scaled for use in things like loyalty programs and supply chain oversight. How has that transition been?

AG: It was more of a natural expansion than a transition. The Sproxil Defender is the flagship mobile product verification solution that is favored and in some cases mandatory for the pharmaceutical manufacturers. However, shortly after we began operations, we realized there was another group of clients; those who needed to fight counterfeiting discreetly by aligning their anti-counterfeiting efforts with their marketing strategy. There were also manufacturers who just wanted to run loyalty programs to boost sales. This led to the development of Sproxil Champion; a loyalty reward solution with built-in fraud protection so that brand owners only reward consumers who buy original products, giving consumers even more of an incentive to verify their goods. Then of course, we needed a solution that could help brands monitor products at every step right from the factory, and plug leaks in their supply chain, which is why we created Sproxil Informer. Consumers have won over $4m in prizes thanks to Sproxil Champion, including a taxi driver who won a Mercedes-Benz after buying a genuine battery!

Customers verifiying at the pharmacyIn the Photo: Customers verifying medications at a pharmacy. Photo Credit: Sproxil.

What kind of impact has Sproxil had on people’s lives? Have you been able to quantify it?

AG: Earlier this year, we surpassed the 50 million mark; meaning that over 50 million times consumers across three continents have been able to communicate with the manufacturers of the products they want to buy, confirm their authenticity, and sometimes get rewarded as well. It’s the highest recorded number of such interactions processed, and we’re quite proud of it.

What does the future of Sproxil look like in your eyes?

AG: We continue to invest in innovation, and have a number of new products being developed. We have seen very strong uptake of Sproxil Champion, opening up new opportunities for us in different industries. We will continue to work with authentic brands around the world to protect consumers and lock out counterfeiters from the value chain.


RELATED ARTICLES

Empty Trips is moving Africa – An interview with Benji Coetzee

Stimulating Innovation and Partnerships With Africa’s Trust Fund

A Clean Act: An Interview with David Auerbach


NOTE: THE OPINIONS EXPRESSED HERE BY IMPAKTER.COM COLUMNISTS ARE THEIR OWN, NOT THOSE OF IMPAKTER.COM.
Tags: CounterfeitDr. Ashifi GogoFraudImpakterLabelmedicineMohamad AkefSproxil
Previous Post

No doubt about it: Climate Change is real

Next Post

Going back to Roots: An Interview with Grassroot

Related Posts

ESG news regarding UK increasing military defense against Russia, first on-site SAF plant in Pittsburgh USA, China electric scooters running on sodium batteries, and online delivery service facing antitrust fines
ESG FINANCE

Cold War 2.0? U.K. Fears Nuclear and Cyber Attacks from Russia

Today’s ESG Updates U.K. to Invest Billions in Defense Upgrades: U.K. announces significant defense spending, including 12 nuclear subs, amid...

bySarah Perras
June 3, 2025
ESG news regarding European Union on track to reach climate target, Brazil suing BYD over labour conditions, Schneider Electric opening nest in Dubai, and the EU’s 150 billion euro investment in increased defence
Business

EU Within Reach of Achieving 2030 Climate Target

Today’s ESG Updates EU Nears 2030 Climate Target: The EU is on track to reduce emissions by 54% by 2030,...

bySarah Perras
May 28, 2025
ESG news regarding EU watchdog criticizing easing of green regulations, Italian fashion brands signing agreement to stop workplace exploitation, bottlenecks in European ports, and the EC accusing Shein of deception
Business

European Watchdog Challenges Diminishing Sustainability Rules

Today’s ESG Updates EU Commission Faces Scrutiny Over Green Rollbacks: European Ombudswoman launches inquiry into Commission’s lack of transparency concerning...

bySarah Perras
May 27, 2025
NetZero Milan Conference discusses renewables, political uncertainty and more.
Energy

Europe’s Energy Transition: Insights From NetZero Summit

Last week, I attended the first-ever NetZero Milan expo-summit in Milan, Italy. The event brought together professionals from all over...

bySarah Perras
May 22, 2025
European Union Deforestation Regulation and its impact on small coffee farmers across the globe
Environment

How the EU’s Deforestation Regulation Could Affect the Coffee Industry

Europe is the largest consumer of coffee in the world. From a tiny cup of espresso in a local Italian...

bySarah Perras
May 9, 2025
ESG news regarding Investment in Europes data centres, women in finance, UK housing sector, ESG fraud risks
Climate Change

Bain Capital and Aquila Group Join Forces to Power Europe’s Data Center Future

Today’s ESG updates cover Bain Capital’s majority stake in AQ Compute to boost sustainable data centres across Europe, growing ESG...

byOliver Stein
October 31, 2024
Cellolabs stem cells
Health

How Startup Cellcolabs Could Revolutionize Stem Cell Production

To date, the majority of stem cells have been obtained from adult stem cells or fetal tissue following termination. But...

byEvi Giourouki
March 14, 2024
World Health Day 2023 — Health for All
Health

World Health Day 2023 — Health for All

Today is World Health Day, April 7, and as this year is the 75th anniversary of the World Health Organisation...

byJessica Mason
April 7, 2023
Next Post
Going back to Roots: An Interview with Grassroot

Going back to Roots: An Interview with Grassroot

Recent News

ESG News regarding Microsoft’s wind power deal with Iberdrola in Spain, OECD and EPO findings on the quantum sector’s maturation, SBTi’s pilot of a net-zero standard for power companies, and the European Commission’s proposed expansion of the Carbon Border Adjustment Mechanism.

Microsoft Signs 150 MW Wind Power Agreements in Spain With Iberdrola 

December 17, 2025
Australia Social Media Age Ban

What Australia’s Social Media Age Ban Really Means

December 17, 2025
women and extreme heat

Women and Extreme Heat: Simple Adaptations Make a Big Difference

December 17, 2025
  • ESG News
  • Sustainable Finance
  • Business

© 2025 Impakter.com owned by Klimado GmbH

No Result
View All Result
  • Environment
    • Biodiversity
    • Climate Change
    • Circular Economy
    • Energy
  • FINANCE
    • ESG News
    • Sustainable Finance
    • Business
  • TECH
    • Start-up
    • AI & Machine Learning
    • Green Tech
  • Industry News
    • Entertainment
    • Food and Agriculture
    • Health
    • Politics & Foreign Affairs
    • Philanthropy
    • Science
    • Sport
  • Editorial Series
    • SDGs Series
    • Shape Your Future
    • Sustainable Cities
      • Copenhagen
      • San Francisco
      • Seattle
      • Sydney
  • About us
    • Company
    • Team
    • Global Leaders
    • Partners
    • Write for Impakter
    • Contact Us
    • Privacy Policy

© 2025 Impakter.com owned by Klimado GmbH